texas oncology more breakthroughs. more victories
Some of our cancer centers may have important notifications found on the location page. View More Important Notifications x

Tobin Strom, M.D.

Tobin Strom, M.D. Photo

Provider Type: Physician

Board Certifications:
  • Radiation Oncology


General Summary

Dr. Tobin Strom is part of the ASTRO Head & Neck Abstract review committee, the Radiation Quality Control committee at Texas Oncology and Radiation Oncology Clinical Excellence & Pathways at US Oncology committee.


  • Residency in Radiation Oncology, Chief Resident
    Moffitt Cancer Center, Tampa, FL
  • Internship in Internal Medicine
    Boston University, Roger Williams Medical Center, Providence, RI
  • Medical Doctorate
    University of Colorado, Denver, CO
  • Bachelors in Computational Biology - with honors
    Brown University, Providence, RI

Accolades & Memberships

  • American Brachytherapy Society
  • American Society for Radiation Oncology
  • Texas Medical Association
  • Texas Radiological Society
  • K05 Research Scientist Award, Moffitt Cancer Center
  • Chief Resident, Moffitt Cancer Center
  • Editorial Recognition, Desmoplastic Melanoma manuscript in Cancer, May 2014
  • Moffitt Scientific Symposium Clinical Research Award
  • NIH Summer Research Grant, University of Colorado Dept. of Pathology
  • Subspecialty Award, Renal and Electrolyte Abstract Submission, Western Student Medical Research Forum, Carmel, CA
  • Honors Award for Molecular Biology Thesis, Brown University
  • Sigma Xi Research Honor Society, Brown University Chapter
  • Wichita County Medical Society

Specialized Training

  • Intensity Modulated Radiation Therapy (IMRT) with Image Guided Radiation Therapy (IGRT)
  • Volumetric Modulated Arc Therapy (VMAT)
  • Cyberknife-based Stereotactic Body Radiotherapy (SBRT)
  • Linac-based Stereotactic Radiosurgery (SRS)
  • High-dose-rate (HDR) & Low-dose-rate (LDR) Brachytherapy for skin, cervical, endometrial, prostate
  • MIM, Pinnacle and Eclipse treatment planning


  • Interferon Is Associated With Improved Survival for Node-Positive Cutaneous Melanoma: A Single-Institution Experience

    Melanoma Management , 2018

  • Patient Choice for High-Volume Center Radiation Impacts Head and Neck Cancer Outcome

    Cancer Medicine, 2018

  • Adjuvant Radiation Provides Survival Benefit for Resected Pancreatic Adenocarcinomas of the Tail

    Journal of Gastrointestinal Oncology, 2018

  • Three-Dimensional Printer-Aided Casting of Soft, Custom Silicone Boluses (SCSBs) for Head and Neck Radiation Therapy

    Practical Radiation Oncology, 2018

  • Tumour Radiosensitivity Is Associated With Immune Activation in Solid Tumours

    European Journal of Cancer, 2017

Show all Publications
  • Regional Radiation Therapy Impacts Outcome for Node Positive Cutaneous Melanoma

    Journal of the National Comprehensive Cancer Network, 2017

  • Staged Reconstruction Brachytherapy Has Lower Overall Cost in Recurrent Soft-Tissue Sarcoma

    Journal of Contemporary Brachytherapy, 2017

  • A Genome-Based Model for Adjusting Radiotherapy Dose (GARD): A Retrospective, Cohort-Based Study

    The Lancet Oncology, 2017

  • Predictors and Survival for Pathologic Tumor Response Grade in Borderline Resectable and Locally Advanced Pancreatic Cancer Treated With Induction Chemotherapy and Neoadjuvant Stereotactic Body Radiotherapy

    Acta Oncologica, 2017

  • Increased Acute Mortality With Chemoradiotherapy for Locally Advanced Head and Neck Cancer in Patients ≥ 70 Years

    Journal of Geriatric Oncology, 2017

  • Effect of Body Mass Index on Operative Outcome After Robotic-Assisted Ivor-Lewis Esophagectomy: Retrospective Analysis of 129 Cases at a Single High-Volume Tertiary Care Center

    Diseases of the Esophagus, 2017

  • Improved Local and Regional Control with Radiation Therapy for Merkel Cell Carcinoma of the Head and Neck

    Head Neck, 2017

  • Management of Oropharyngeal Cancer in the HPV Era

    Cancer Control, 2016

  • Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma

    Annals of Surgical Oncology, 2016

  • Stereotactactic Radiotherapy for Recurrent Unresectable Head and Neck Cancer

    Cancer Control, 2016

  • Determining Optimal Follow-Up in the Management of Human Papillomavirus-Positive Oropharyngeal Cancer

    Cancer, 2016

  • Treatment Delays, Race, and Outcomes in Head and Neck Cancer

    Cancer Epidemiol, 2016

  • Favorable Perioperative Outcomes After Resection of Borderline Resectable Pancreatic Cancer Treated With Neoadjuvant Stereotactic Radiation and Chemotherapy Compared With Upfront Pancreatectomy for Resectable Cancer

    Journal of Gastrointestinal Oncology, 2016

  • Radiotherapy for Management of Basal Cell Carcinoma and Squamous Cell Carcinoma of the Head and Neck

    Cancer Control, 2016

  • Having Medicaid Insurance Negatively Impacts Outcomes in Patients With Head and Neck Malignancies

    Cancer, 2016

  • Outcomes of Mucosal Melanoma of the Head and Neck

    Journal of Medical Imaging and Radiation Oncology, 2016

  • Health-Related Quality-of-Life Changes Due to High-Dose-Rate Brachytherapy, Low-Dose-Rate Brachytherapy, or Intensity-Modulated Radiation Therapy for Prostate Cancer

    Brachytherapy, 2015

  • Radiotherapy for Management of Basal and Squamous Cell Carcinoma

    Current Problems in Cancer, 2015

  • Radiosensensitivity Index Predicts for Survival with Adjuvant Radiation in Resectable Pancreatic Cancer

    Radiotherapy and Oncology, 2015

  • Dosimetric Coverage of the Prostate, Normal Tissue Sparing, and Acute Toxicity With High-Dose-Rate Brachytherapy for Large Prostate Volumes

    International Brazilian Journal of Urology, 2015

  • Potential Role for LINAC-Based Stereotactic Radiosurgery for the Treatment of 5 or More Radioresistant Melanoma Brain Metastases

    Journal of Neurosurgery, 2015

  • Comparison of Every 3 Week Cisplatin or Weekly Cetuximab with Concurrent Radiotherapy for Locally Advanced Head and Neck Cancer

    Oral Oncology, 2015

  • Quality of Life After High-Dose-Rate Brachytherapy Monotherapy for Prostate Cancer

    International Brazilian Journal of Urology, 2015

  • Comparative Long-Term Outcomes of Upfront Resected Pancreatic Cancer after Preoperative Biliary Drainage

    Surgical Endoscopy, 2015

  • Long-Term Outcomes of Induction Chemotherapy and Neoadjuvant Stereotactic Body Radiotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

    Acta Oncologica, 2015

  • Resected Pancreatic Cancer Outcomes in the Elderly

    Journal of Geriatric Oncology, 2015

  • A Dosimetric Comparison of Volumetric Modulated Arc Therapy With Step-and-Shoot Intensity Modulated Radiation Therapy for Prostate Cancer

    Practical Radiation Oncology, 2015

  • Clinical Implications of a Prostate-Specific Antigen Bounce After Radiation Therapy for Prostate Cancer

    International Journal of Clinical Oncology, 2015

  • Outcomes of Resected Pancreatic Cancer in Patients Age ≥70

    Journal of Gastrointestinal Oncology, 2015

  • Radiation Therapy Improves Outcomes with Desmoplastic Melanoma of the Head and Neck

    American Radium Society, Kauai, 2015

  • A Dosimetric Study of Polyethylene Glycol Hydrogel in 200 Prostate Cancer Patients Treated with High-Dose Rate Brachytherapy ± Intensity Modulated Radiation Therapy

    Florida Prostate Cancer Research Symposium, 2014

  • External Beam Radiation Therapy and a Low-Dose-Rate Brachytherapy Boost Without or With Androgen Deprivation Therapy for Prostate Cancer

    International Journal of Brazilian Urology, 2014

  • Radiotherapy Influences Local Control in Desmoplastic Melanoma

    Cancer, 2014

  • A Dosimetric Study of Polyethylene Glycol Hydrogel in 200 Prostate Cancer Patients Treated with High-Dose Rate Brachytherapy ± Intensity Modulated Radiation Therapy

    Radiotherapy and Oncology, 2014

  • High-Dose Rate Brachytherapy With or Without Intensity Modulated Radiation Therapy As Salvage Treatment for an Isolated, Gross Local Recurrence of Prostate Cancer Post-Prostatectomy

    Brachytherapy, 2014

  • Risk Factors for PEG Tube During Chemoradiotherapy for Oropharynx Cancer

    JAMA Otolaryngology, 2013

  • Low-Dose, Involved Field Radiotherapy Just Prior to Radioimmunotherapy for Relapsed/Refractory B-Cell Lymphoma

    American Society for Radiation Oncology, 2013

  • Risk Factors for Placement of a Percutaneous Endoscopic Gastrostomy Tube During Chemoradiotherapy for Oropharyngeal Squamous Cell Carcinoma

    American Head and Neck Society, 2013

  • Primary Radiotherapy for Locally Advanced Skin Cancer Near the Eye

    Practical Radiation Oncology, 2012

  • Structural Identification of SAR-943 Metabolites Generated by Human Liver Microsomes In Vitro Using Mass Spectrometry in Combination With Analysis of Fragmentation Patterns

    Journal of Mass Spectrometry, 2011

  • Development and Validation of a Semi-Automated Assay for the Highly Sensitive Quantification of Biolimus A9 in Human Whole Blood Using High-Performance Liquid Chromatography-Tandem Mass Spectrometry

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2009

  • Characterization of Sirolimus Metabolites in Pediatric Solid Organ Transplant Recipients

    Pediatric Transplantation, 2009

  • Rare Nerve Lesions of Non-Nerve Sheath Origin: A 17-Year Retrospective Series

    Archives of Pathology & Laboratory Medicine, 2009

  • Rare Nerve Lesions of Non-Nerve Sheath Origin

    Western Student Medical Research Forum, 2009

  • Crossreactivity of Isolated Everolimus Metabolites With the Innofluor Certican Immunoassay for Therapeutic Drug Monitoring of Everolimus

    Therapeutic Drug Monitoring, 2007

  • Identification of Everolimus Metabolite Patterns in Trough Blood Samples of Kidney Transplant Patients

    Therapeutic Drug Monitoring, 2007

  • Assessment and Validation of the MS/MS Fragmentation Patterns of the Macrolide Immunosuppressant Everolimus

    Journal of Mass Spectrometry, 2007

  • Active Drug Transport of Immunosuppressants: New Insights for Pharmacokinetics and Pharmacodynamics

    Therapeutic Drug Monitoring, 2006

  • Development and Validation of a High-Throughput Assay for Quantification of the Proliferation Inhibitor ABT-578 using LC/LCMS/MS in Blood and Tissue Samples

    Therapeutic Drug Monitoring, 2005

  • Cross-Reactivity of the Major Everolimus Hydroxy Metabolites With the Innofluor® Certican Immunoassay for Clinical TDM of Everolimus

    International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, 2005

Research Interest

Dr. Strom specializes in all disease sites, and has published articles on head & neck, skin, gastrointestinal, and genitourinary cancers in several peer-reviewed journals. His research has been presented nationally at American Society of Therapeutic Radiology and Oncology, American Radium Society and American Society of Clinical Oncology meetings.

Other Information

When not treating patients or editing medical publications, Dr. Strom spends his time with his wife and two daughters. He and his family enjoy camping, riding bikes, exploring Texas, and cheering at the girls’ soccer matches and swim meets.